Real-world data presented at the American Society of Retina Specialists annual meeting highlights new medications capable of slowing geographic atrophy and dry AMD progression, supported by advanced imaging biomarkers.
-
Intentional weight loss reduces the mechanical stimulus necessary to maintain bone mass. Discover expert insights on whether weighted vests can serve as a bone-preserving adjunct during weight reduction.
- CardiologyDERMATOLOGYPREVENTIVE MEDICINE
Incidental Coronary Artery Calcium in Psoriatic Disease: CV Risk & Statin Gaps
Psoriasis is a systemic inflammatory condition associated with increased cardiovascular risk. Research from ASPC 2026 demonstrates how incidental coronary artery calcium findings on routine chest CTs can pinpoint high-risk patients …
-
Glenmark Pharmaceuticals has received FDA approval for its fluticasone propionate nasal spray USP (0.05 mg per spray), offering a bioequivalent and therapeutically equivalent alternative to Flonase for allergy relief in …
-
The FDA has granted clearance to PrecivityAD2, a breakthrough blood test by C2N Diagnostics designed to help healthcare professionals evaluate Alzheimer’s disease pathology in symptomatic adults aged 40 and older …
-
Dr. Richard L. Lindstrom examines the critical challenges of undiagnosed glaucoma and poor long-term drop compliance, advocating for a transition toward interventional glaucoma (IG) featuring primary selective laser trabeculoplasty (SLT) …
-
Clinical experts discuss the paradigm shift toward interventional glaucoma, emphasizing the mindful use of topical medications, the proven benefits of selective laser trabeculoplasty (SLT), and advanced options like MIGS and …
Artificial intelligence offers immense promise for streamlining rheumatology workflows, but unchecked adoption risks serious clinical errors. Discover key takeaways from AWIR on using ambient scribes, verifying AI logic, and keeping …
The FDA has granted marketing authorization to 11 Zyn Ultra nicotine pouch products from Swedish Match USA, providing lower-constituent toxicity alternatives intended for adult tobacco user substitution.
A recent JAMA Neurology study reveals that inebilizumab significantly reduces disease exacerbations and the need for rescue therapy in patients with generalized myasthenia gravis (gMG), offering critical insights into outpatient …